Page last updated: 2024-08-23

haloperidol decanoate and Lymphopenia

haloperidol decanoate has been researched along with Lymphopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P1

Other Studies

1 other study(ies) available for haloperidol decanoate and Lymphopenia

ArticleYear
Neuroleptic malignant syndrome in a COVID-19 patient.
    Brain, behavior, and immunity, 2020, Volume: 88

    Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia

2020